• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的强效、构象受限的Smac模拟物设计。

Structure-based design of potent, conformationally constrained Smac mimetics.

作者信息

Sun Haiying, Nikolovska-Coleska Zaneta, Yang Chao-Yie, Xu Liang, Liu Meilan, Tomita York, Pan Hongguang, Yoshioka Yoshiko, Krajewski Krzysztof, Roller Peter P, Wang Shaomeng

机构信息

Departments of Internal Medicine and Medicinal Chemistry and Comprehensive Cancer Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA.

出版信息

J Am Chem Soc. 2004 Dec 29;126(51):16686-7. doi: 10.1021/ja047438+.

DOI:10.1021/ja047438+
PMID:15612682
Abstract

A successful structure-based design and synthesis of a class of highly potent conformationally constrained Smac mimetics is described. The most potent compound has a Ki value of 25 nM binding to the XIAP BIR3 protein and is 23 times more potent than natural Smac peptides. These potent Smac mimetics can serve as powerful chemical and pharmacological tools to further elucidate the role of Smac and its cellular binding partners in apoptosis regulation and may be developed as a new class of anti-cancer drugs.

摘要

本文描述了一类基于结构的高效构象受限Smac模拟物的成功设计与合成。最有效的化合物与XIAP BIR3蛋白结合的Ki值为25 nM,比天然Smac肽的效力高23倍。这些强效的Smac模拟物可作为强大的化学和药理学工具,以进一步阐明Smac及其细胞结合伴侣在细胞凋亡调控中的作用,并可能开发成为一类新型抗癌药物。

相似文献

1
Structure-based design of potent, conformationally constrained Smac mimetics.基于结构的强效、构象受限的Smac模拟物设计。
J Am Chem Soc. 2004 Dec 29;126(51):16686-7. doi: 10.1021/ja047438+.
2
Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics.基于结构的新型强效Smac拟肽的设计、合成及生化测试
Bioorg Med Chem Lett. 2005 Feb 1;15(3):793-7. doi: 10.1016/j.bmcl.2004.11.008.
3
Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.基于结构的设计、合成以及对靶向X连锁凋亡抑制蛋白/半胱天冬酶-9相互作用位点的线粒体衍生的半胱天冬酶激活剂-2构象受限模拟物的评估。
J Med Chem. 2004 Aug 12;47(17):4147-50. doi: 10.1021/jm0499108.
4
Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains.基于Smac的双价肽作为XIAP拮抗剂的设计与表征以及针对包含BIR2和BIR3结构域的XIAP的荧光偏振测定法的开发与验证。
Anal Biochem. 2008 Mar 1;374(1):87-98. doi: 10.1016/j.ab.2007.10.032. Epub 2007 Nov 20.
5
Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.一种通过拮抗凋亡抑制蛋白使癌细胞对凋亡敏感的强效Smac模拟物的设计、合成及生物学活性
ACS Chem Biol. 2006 Sep 19;1(8):525-33. doi: 10.1021/cb600276q.
6
Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.IAP蛋白家族中双价Smac模拟物识别的结构基础。
J Mol Biol. 2009 Sep 25;392(3):630-44. doi: 10.1016/j.jmb.2009.04.033. Epub 2009 Apr 22.
7
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.Smac/DIABLO与XIAP BIR3结构域结合的结构基础。
Nature. 2000;408(6815):1004-8. doi: 10.1038/35050006.
8
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.发现用于癌症治疗的抗凋亡蛋白XIAP的强效拮抗剂。
J Med Chem. 2004 Aug 26;47(18):4417-26. doi: 10.1021/jm040037k.
9
Theoretical studies on the interactions of XIAP-BIR3 domain with bicyclic and tricyclic core monovalent Smac mimetics.XIAP-BIR3 结构域与双环和三环核心单价 Smac 模拟物相互作用的理论研究。
J Mol Graph Model. 2010 Nov;29(3):354-62. doi: 10.1016/j.jmgm.2010.09.011. Epub 2010 Oct 25.
10
Design of small-molecule peptidic and nonpeptidic Smac mimetics.小分子肽类和非肽类Smac模拟物的设计。
Acc Chem Res. 2008 Oct;41(10):1264-77. doi: 10.1021/ar8000553.

引用本文的文献

1
ARTS and small-molecule ARTS mimetics upregulate p53 levels by promoting the degradation of XIAP.ARTS 和小分子 ARTS 模拟物通过促进 XIAP 的降解来上调 p53 水平。
Apoptosis. 2024 Aug;29(7-8):1145-1160. doi: 10.1007/s10495-024-01957-2. Epub 2024 Apr 29.
2
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy.载有细胞凋亡诱导型 SMAC 肽-阿霉素前药的癌组织靶向阿波莫斯用于协同癌症免疫治疗
J Nanobiotechnology. 2024 Mar 13;22(1):109. doi: 10.1186/s12951-024-02314-w.
3
Small molecules targeting protein-protein interactions for cancer therapy.
靶向蛋白质-蛋白质相互作用的小分子用于癌症治疗。
Acta Pharm Sin B. 2023 Oct;13(10):4060-4088. doi: 10.1016/j.apsb.2023.05.035. Epub 2023 Jun 1.
4
Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System.降解致死:泛素-蛋白酶体系统对细胞凋亡的调控。
Cells. 2021 Dec 8;10(12):3465. doi: 10.3390/cells10123465.
5
The Discovery of Conformationally Constrained Bicyclic Peptidomimetics as Potent Hepatitis C NS5A Inhibitors.构象受限双环肽模拟物作为强效丙型肝炎NS5A抑制剂的发现
ACS Med Chem Lett. 2021 Sep 15;12(11):1649-1655. doi: 10.1021/acsmedchemlett.1c00391. eCollection 2021 Nov 11.
6
Analysis of physicochemical properties of protein-protein interaction modulators suggests stronger alignment with the "rule of five".蛋白质-蛋白质相互作用调节剂的物理化学性质分析表明,其与“五规则”的契合度更高。
RSC Med Chem. 2021 Jul 27;12(10):1731-1749. doi: 10.1039/d1md00213a. eCollection 2021 Oct 20.
7
Targeting XIAP for Promoting Cancer Cell Death-The Story of ARTS and SMAC.靶向 XIAP 促进癌细胞死亡——ARTS 和 SMAC 的故事。
Cells. 2020 Mar 9;9(3):663. doi: 10.3390/cells9030663.
8
Development of XIAP Antagonists Based On De Novo 8,5-Fused Bicyclic Lactams.基于从头设计的8,5-稠合双环内酰胺开发X连锁凋亡抑制蛋白拮抗剂。
ChemistryOpen. 2019 Jan 15;8(1):34-40. doi: 10.1002/open.201800260. eCollection 2019 Jan.
9
Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach.基于热力学驱动方法设计高效的 pan-IAP 和 Lys-C 共价 XIAP 选择性抑制剂。
J Med Chem. 2018 Jul 26;61(14):6350-6363. doi: 10.1021/acs.jmedchem.8b00810. Epub 2018 Jul 9.
10
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs).通过靶向凋亡蛋白抑制剂(IAPs)克服化疗药物耐药性。
Apoptosis. 2017 Jul;22(7):898-919. doi: 10.1007/s10495-017-1375-1.